Status:
COMPLETED
Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section
Lead Sponsor:
B.P. Koirala Institute of Health Sciences
Conditions:
Non Elective Cesarean Section and Ketamine Analgesia
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
This randomized double blind study will be conducted in pregnant woman planned for non elective cesarean section under spinal anesthesia. Ketamine group will receive intravenous 0.25 mg/kg and placebo...
Eligibility Criteria
Inclusion
- • All women at term(\>or =37 weeks of gestation)
- Healthy
- American Society of Anesthesiologists(ASA) class1 and 2
- Women undergoing non-elective caesarean section whose anesthetic plan is for spinal anesthesia with bupivacaine and fentanyl
Exclusion
- • Women with American society of anesthesiologist physical status\>2
- Body mass index \>or =40 kg per square meter
- Height \<150 cm
- Any contraindication to the spinal anesthesia
- History of substance abuse
- History of hallucinations
- Chronic opioid therapy
- Chronic pain or on any pain medication currently
- Patient with maternal complications,like cardiovascular disease pre-eclampsia,diabetes,multiple gestation,known fetal abnormality
- Cases with severely compromised fetus where immediate administration of general anesthesia is required.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03450499
Start Date
April 1 2018
End Date
March 7 2019
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BP Koirala Institute of Health Sciences (BPKIHS)
Dharān, Koshi, Nepal, 56700